Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings - Colgate-Palmolive (NYSE:CL)

Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, exceeding the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Group 1: Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange fluctuations [3] Group 2: Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program to enhance growth despite global market uncertainties [2] - Organic sales growth is projected at 1%–2%, which includes a ~70 basis points impact from exiting private-label pet sales [3] Group 3: Analyst Ratings and Price Targets - Following the earnings announcement, various analysts adjusted their price targets for Colgate-Palmolive, with Wells Fargo lowering its target from $80 to $77 and Evercore ISI Group from $100 to $94 [4][6] - JP Morgan and Morgan Stanley both maintained an Overweight rating while lowering their price targets to $87 from $88 and $96 respectively [6] - Citigroup maintained a Buy rating but reduced its price target from $105 to $95 [6]